Related Experiment Video

Updated: Mar 28, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

3.8K

[Risk of seizure recurrence after a first unprovoked seizure in childhood]

Yuichi Takami, Eriko Satake, Hirofumi Ban

    No to Hattatsu = Brain and Development
    |January 1, 2016
    PubMed

    Insights

    The risk of seizure recurrence after a first unprovoked seizure in childhood is significant, with over half of children experiencing a repeat seizure within one year. Key risk factors include abnormal EEG and prior febrile seizures.

    Area of Science:

    • Pediatric Neurology
    • Epilepsy Research
    • Clinical Epidemiology

    Background:

    • First unprovoked seizures in children represent a common neurological event.
    • Understanding seizure recurrence risk is crucial for clinical management and prognosis.
    • Current guidelines on post-seizure treatment remain debated.

    Purpose of the Study:

    • To prospectively evaluate the recurrence risk following a first unprovoked seizure in a pediatric cohort.
    • To identify specific risk factors associated with seizure recurrence in children.

    Main Methods:

    • Prospective observational study involving 250 children (1 month to 16 years) with a first unprovoked seizure.
    • No anti-seizure medication was administered after the initial event.
    • Kaplan-Meier analysis calculated recurrence rates; Cox proportional hazards models identified risk factors.

    Main Results:

    • A high recurrence rate of 54% was observed in the study cohort.
    • Seventy percent of recurrences occurred within six months of the initial seizure.
    • Identified risk factors for recurrence included remote symptomatic etiology, abnormal electroencephalography (EEG), age 8 years or older, and a history of febrile seizures.

    Conclusions:

    • Routine treatment after a first unprovoked seizure in children is not recommended.
    • Clinical decisions should incorporate the assessed recurrence rates and identified risk factors.
    • Further research into targeted interventions based on risk stratification is warranted.
    Abstract

    More Related Videos

    Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice07:01

    Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

    Published on: May 16, 2019

    9.7K
    Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy10:22

    Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

    Published on: December 6, 2016

    21.3K

    Related Concept Videos

    Seizures: Classification01:13

    Seizures: Classification

    Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
    Seizures are typically classified into two main categories: focal and generalized seizures.
    Focal Seizures
    Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
    2.2K
    Epilepsy and Seizures: Overview01:24

    Epilepsy and Seizures: Overview

    Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
    Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
    1.7K
    Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

    Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

    Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
    SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
    1.1K
    Antiepileptic Drugs: Potassium Channel Activators01:20

    Antiepileptic Drugs: Potassium Channel Activators

    Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
    Ezogabine has gained approval as an adjunctive treatment...
    949
    Antiepileptic Drugs: Sodium Channel Blockers01:08

    Antiepileptic Drugs: Sodium Channel Blockers

    Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
    Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
    Among the most commonly prescribed antiepileptic drugs are...
    2.3K
    Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

    Antiepileptic Drugs: GABAergic Pathway Potentiators

    γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
    The key GABA pathway potentiators used in epilepsy management are as follows.
    Benzodiazepines are a well-known class of drugs used for...
    1.6K